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Introduction
Human embryonic stem cells (ESCs [hESCs]), derived from 
the inner cell mass of blastocyst-stage human embryos, can 
self-renew in culture indefinitely and have the remarkable 
potential to develop into nearly all differentiated cell types 
(Thomson et al., 1998), allowing them to be used for bio-
medical research, drug discovery, and cell-based therapies 
(Daley and Scadden, 2008; Rossant, 2008). hESC long-term 
self-renewal  requires  cell  proliferation  and  survival  with   
continuous repression of differentiation. Recent studies have   
revealed  some  important  molecular  elements  that  support   
hESC long-term undifferentiated growth and survival. Extrinsic 
factors  such  as  basic  FGF  (bFGF;  Thomson  et  al.,  1998;   
Levenstein  et  al.,  2006),  TGF-  (Xu  et  al.,  2008),  and   
insulin-like growth factor 1 (Bendall et al., 2007) are required 
for stability of a network of transcription factors including 
OCT-4, NANOG, and SOX2, which function in concert to posi-
tively regulate target genes necessary for pluripotency and 
repress a variety of lineage specification factors (Jaenisch 
and Young, 2008). Receptor tyrosine kinases, including ERBB2 
and insulin-like growth factor 1 receptor (Wang et al., 2007), 
are necessary for hESC proliferation and survival. The sig-
nals from the extrinsic factors are integrated by intracellular 
molecules, such as mammalian target of rapamycin (mTOR; 
Zhou et al., 2009), to repress differentiation activities and/or 
H
uman embryonic stem cells (ESCs [hESCs]) prolif-
erate  as  colonies  wherein  individual  cells  are 
strongly adhered to one another. This architecture 
is linked to hESC self-renewal, pluripotency, and survival 
and depends on epithelial cadherin (E-cadherin), NMMIIA 
(nonmuscle myosin IIA), and p120-catenin. E-cadherin 
and p120-catenin work within a positive feedback loop 
that promotes localized accumulation of E-cadherin at   
intercellular junctions. NMMIIA stabilizes p120-catenin 
protein  and  controls  E-cadherin–mediated  intercellular 
adhesion. Perturbations of this signaling network disrupt 
colony formation, destabilize the transcriptional regula-
tory  circuitry  for  pluripotency,  and  impair  long-term   
survival of hESCs. Furthermore, depletion of E-cadherin 
markedly reduces the efficiency of reprogramming of   
human somatic cells to an ESC-like state. The feedback 
regulation and mechanical–biochemical integration pro-
vide mechanistic insights for the regulation of intercellular 
adhesion and cellular architecture in hESCs during long-
term self-renewal. Our findings also contribute to the   
understanding of microenvironmental regulation of hESC 
identity and somatic reprogramming.
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Results
Inhibition of NMMII causes profound 
defects in hESCs
To identify the regulatory components of pluripotency in hESCs, 
we screened a collection of pharmacological inhibitors against 
kinases and other signaling molecules. To eliminate indirect   
effects of feeders on hESCs, we used feeder-free culture condi-
tions, under which untreated control cells grew as compact and 
tight colonies with well-defined edges (Fig. 1 A; Xu et al., 
2001). We passaged hESCs as small cell clusters, a condition 
known to improve cell survival. This screening effort led us to 
identify mTOR as a central regulator of hESC pluripotency 
(Zhou et al., 2009). With this screen, we also found that treat-
ment of cells with blebbistatin, a highly specific inhibitor of 
NMMII (Straight et al., 2003), induced profound morphological 
changes in H9 hESCs. Blebbistatin-treated cells formed poorly 
developed colonies in which a significant fraction of cells were 
dissociated from one another and spread out as single cells   
(Fig. 1 A; several representative cell morphologies are shown in 
Fig. S1 A). The effect of blebbistatin on colony formation was 
dose dependent, with an inhibitory concentration for 50% inhi-
bition (IC50; disruption of 50% of colonies) of 4 µM, which 
is close to the reported IC50 value for inhibiting ATPase activity 
of myosin II (2 µM; Straight et al., 2003). Exposure of cells to 
10 µM blebbistatin caused the poorly aggregated colonies to   
increase from 9 (for control cells) to 82% (Table S1). This dose 
was used for the rest of the experiments.
Disruption of colony integrity is often associated with al-
tered expression of pluripotency markers. Indeed, blebbistatin 
treatment reduced the activity of AP (an ESC marker) and the 
levels of SOX2, NANOG, and OCT-4 proteins in H9 cells (Fig. 1, 
B and C; and Fig. S1 B; quantification of SOX2, NANOG, and 
OCT-4 levels is shown in Table S1). SOX2, NANOG, and OCT-4 
are components of the core transcriptional regulatory circuitry 
for pluripotency (Jaenisch and Young, 2008) and have also 
been used to derive human and mouse iPSCs (Takahashi and   
Yamanaka, 2006; Takahashi et al., 2007; Yu et al., 2007; Park   
et al., 2008). Interestingly, the mRNA levels of POU5F1 (the 
gene  encoding  OCT-4),  SOX2,  and  NANOG  decreased  only 
slightly after blebbistatin treatment (Fig. S1 C), indicating that 
the  regulation  largely  occurred  posttranscriptionally.  Blebbi-
statin’s effect on the pluripotency factors was also observed in 
H1 hESCs (Thomson et al., 1998), a human iPSC (hiPSC) line 
MMW2 (Mali et al., 2010) and W4/129 mouse ESCs (mESCs; 
Fig. S1, D–F), implying a conserved function of NMMII in   
pluripotent stem cells. Furthermore, although blebbistatin treat-
ment for 5 d exerted little effect (blebbistatin-treated cells, 7 ± 4%; 
vs. control cells, 5 ± 3%), long-term treatment (>7 d) caused in-
creased apoptosis in hESCs (17 ± 7%; vs. control cells on day 8, 
6 ± 3%; P < 0.001). The increase in apoptosis was likely the re-
sult of the gradual loss of cellular association after prolonged 
treatment. It is well known that cellular association is required 
for survival of hESCs (Watanabe et al., 2007).
To ask whether NMMII inhibition also impaired de novo 
colony formation in hESCs, we assessed the effects of blebbi-
statin on hESCs plated as single cells. Interestingly, blebbistatin 
promote  proliferation  and  survival  of  hESCs.  Despite  the   
understanding of hESC regulation by soluble factors, little is 
known mechanistically about how other microenvironmental 
factors including cell–cell and cell–ECM interactions control 
hESC functions.
In  this  study,  we  investigate  a  distinctive  feature  of 
hESCs. Like ESCs established from other species, hESCs pro-
liferate in culture as tight and compact colonies, wherein cells 
are  associated  strongly  with  one  another  (Thomson  et  al., 
1998). The compact structure of hESCs appears integral to the 
normal functions of hESCs. Perturbations of hESC pluripo-
tency as the result of the removal or inhibition of key extrinsic 
factors,  intracellular  signaling  molecules,  and  transcription 
factors  are  associated  with  profound  changes  in  cell  and   
colony  morphologies  (Levenstein  et  al.,  2006;  Okita  and   
Yamanaka, 2006; Zhou et al., 2009). One of the changes is 
loss of colony integrity and disruption of proper intercellular 
interactions. Therefore,  maintenance  of  cellular  association 
and colony integrity is a widely accepted indicator of the ESC 
state. Accordingly, in the recent derivation of induced pluripo-
tent stem cells (iPSCs) from somatic cells, development of 
compact colonies with tight cellular association has been used 
as a simple and reliable readout for conversion of non-ESCs to 
an ESC-like state (Takahashi and Yamanaka, 2006; Takahashi 
et al., 2007; Yu et al., 2007; Park et al., 2008). Despite the evi-
dent role of cellular association in regulating hESC functions, 
the mechanisms and molecular connections to pluripotency 
remain largely undefined.
Cadherins (calcium-dependant adhesion molecules) are 
a class of type 1 transmembrane proteins that play important 
roles in intercellular cell adhesion (Takeichi, 1995). In partic-
ular, epithelial cadherin (E-cadherin) plays a pivotal role in 
tissue morphogenesis, development, tumorigenesis, and sig-
nal transduction (Gumbiner, 2005). E-cadherin is highly ex-
pressed  in  hESCs,  and  inhibition  of  E-cadherin  function 
impairs cell survival (Li et al., 2010; Xu et al., 2010). -Catenin 
and p120-catenin bind the cytoplasmic domain of E-cadherin 
and are critical regulators of E-cadherin functions (Cowin and 
Burke, 1996; Davis et al., 2003; Xiao et al., 2003). -Catenin, 
an actin-binding protein, regulates interaction of the E-cadherin– 
-catenin complex with the actin cytoskeleton (Drees et al., 
2005; Yamada et al., 2005). -, -, and p120-catenin have 
established roles in early development; ablation or depletion 
of these molecules caused embryonic lethality in mice and 
other animals (Haegel et al., 1995; Torres et al., 1997; Fang 
et al., 2004; unpublished data). The roles of -, -, and p120-
catenin in regulating hESC adhesion and pluripotency have 
not been explored. This can be largely attributed to the diffi-
culties  associated  with  genetic  manipulations  of  hESCs,   
including the use of RNAi-mediated knockdown of genes   
of interest.
In this study, we identified a highly integrated signaling 
network that controls intercellular adhesion in hESCs. This net-
work contains NMMIIA (nonmuscle myosin IIA), E-cadherin, 
and p120-catenin and is essential for colony formation, stability 
of the transcriptional regulatory circuitry for pluripotency, and 
long-term survival of hESCs.633 Biomechanical signals control hESC functions • Li et al.
SOX2 proteins (Fig. S1 H). Thus, NMMII is necessary for sta-
bility of the OCT-4–SOX2–NANOG circuitry and colony for-
mation in hESCs, regardless of whether they are plated as single 
cells or small clusters.
We next determined whether the changes induced by   
myosin II inhibition were reversible. To test this, we removed 
blebbistatin from cells after a 3-d treatment and allowed them   
to continue to grow for 3 d without blebbistatin. In a separate 
experiment, we incubated the cells with blebbistatin for 5 d, 
treatment increased the number of surviving single cells (from 
7 to 35%) 24 h after plating (Fig. S1 G), which is consistent 
with a previous report that inhibition of ROCK or other compo-
nents of the Rho–ROCK–NMMII cascade improved survival   
of dissociated hESCs (Watanabe et al., 2007; Xu et al., 2010). 
Under this condition, prolonged blebbistatin treatment mark-
edly impaired colony formation and increased the colonies with 
poor cellular association to 86% (Fig. S1 G and not depicted). 
The treatment also reduced the levels of OCT-4, NANOG, and 
Figure 1.  NMMIIA but not NMMIIB is necessary for multifaceted hESC functions. (A) Phase-contrast images of H9 cells cultured under feeder-free conditions 
with or without the following treatments: 10 µM blebbistatin (5 d), nontargeting shRNA (NT shRNA), NMMIIA, or NMMIIB shRNAs (4 d). (B) AP staining 
of H9 cells with or without 10 µM blebbistatin treatment (5 d). More images are shown in Fig. S1 A. (A and B) Bars, 100 µm. (C) Western blot analysis of 
OCT-4, SOX2, and NANOG proteins in H9 cells treated with or without 10 µM blebbistatin (5 d). A typical blot is shown, and quantification of blots from 
four separate experiments is shown in Table S1. -Tubulin was a loading control. (D and E) Western blot analysis of NMMIIA/NMMIIB, OCT-4, SOX2, 
and NANOG proteins in H9 cells with or without NMMIIA/NMMIIB depletion (4 d). Three different shRNAs targeting NMMIIA (D) or NMMIIB (E) were 
used. Cells without lentiviral infection (no infection) or treated with nontargeting shRNA were used as negative controls. Quantifications of blots from four 
separate experiments for NMMIIA and NMMIIB depletion are shown in Table S1. Cells infected with nontargeting shRNA exhibited similar values to cells 
without infection. (F) Western blot analysis of NMMIIA or NMMIIB in H9 cells with NMMIIA or NMMIIB depletion, respectively.JCB • VOLUME 191 • NUMBER 3 • 2010   634
Figure 2.  NMMIIA modulates E-cadherin adhesion and protein expression in hESCs. (A) Fluorescence and phase-contrast images of H9 cells stained with 
antibodies against NMMIIA and E-cadherin. (B) Immunofluorescence experiments of E-cadherin in H9 with NMMIIA depletion (for 4 d) or treated with 10 µM 
blebbistatin for 24 h or 4 d. Corresponding phase-contrast images of the cells are also shown. (A and B) Insets show fractions of fluorescence images 
at a higher magnification. Bars, 100 µm. (C) Relative cell adhesion to the E-cadherin substrate hE/Fc with or without 10 µM blebbistatin treatment (2 h). 
Values were normalized to the number (100%) of control cells. Results from five separate experiments are shown. Student’s t tests compared data between 
the two experimental groups. (D) Representative traction maps for hESCs plated on elastic polyacrylamide gels coated with hE/Fc with or without blebbi-
statin treatment. The pseudocolor bar represents tractions. Bar, 5 µm. (E) Mean tractions in control cells and cells with blebbistatin treatment. Cells were 
analyzed 1 h after being plated on elastic polyacrylamide gel coated with hE/Fc. A customized MATLAB program (MathWorks) was used to calculate the 
traction values. (F) Western blot analysis of E-cadherin, OCT-4, and SOX2 proteins in H9 cells treated or not with 10 µM blebbistatin for various times. 635 Biomechanical signals control hESC functions • Li et al.
replated the cells, and allowed them to grow for 5 d in the ab-
sence of blebbistatin. Under both conditions, cells with prior 
treatment were able to resume their original cellular morphol-
ogy and rescue the levels of pluripotency proteins when cul-
tured without blebbistatin (Fig. S1, I and J; and not depicted).
Disruption of the OCT-4–NANOG–SOX2 circuitry often 
causes differentiation activities in hESCs (Jaenisch and Young, 
2008), leading us to examine the expression of lineage-specific 
differentiation markers in blebbistatin-treated cells. Blebbistatin 
treatment for 5 d enhanced expression of lamin A/C (Fig. S1 K), 
which was reportedly activated upon differentiation of mouse 
and hESCs (Constantinescu et al., 2006) but only induced slight 
up-regulation  of  NEUROD1  (ectoderm),  MESP1,  MIXL1  
(mesoderm), GATA4, GATA6 (endoderm), CDX2, and CGB7 
(trophoectoderm) (Fig. S1 L and not depicted).
Depletion of NMMIIA but not NMMIIB 
mimics blebbistatin treatment
NMMIIs are actin-binding proteins that regulate the contractile 
functions in cells. Of the three different NMMII isoforms iden-
tified, two (NMMIIA and NMMIIB) are almost ubiquitously 
found in higher organisms and are essential for development. 
Deletion of NMMIIA or NMMIIB in mice leads to embryonic 
lethality (Tullio et al., 1997; Conti et al., 2004). However, NMMIIA 
knockout leads to lethality in periimplantation stage embryos, 
whereas NMMIIB-null mice die late in gestation. hESCs, like 
mESCs (Conti et al., 2004), express both NMMIIA and NMMIIB 
(Fig. 1, D and E). To verify the specificity of blebbistatin and 
identify the NMMII isoforms required for hESC colony integ-
rity and stability of the transcriptional circuitry for pluripotency, 
we exploited RNAi-induced knockdown to deplete NMMIIA 
and NMMIIB in hESCs. By infecting the cells with shRNA-
containing lentivirus followed by puromycin selection, we 
achieved consistent knockdown of genes of interest in hESCs 
(see following paragraphs; Fig. 1 D; the effect of OCT-4 knock-
down is shown in Fig. S2, A and B). To ensure specificity,   
we used at least two shRNAs to deplete the same target genes. 
Depletion of NMMIIA for 4 d sharply increased the proportion 
of colonies with poor cellular association (from 11% for control 
cells to 78%; Fig. 1 A) and markedly down-regulated OCT-4, 
NANOG, and SOX2 proteins (Fig. 1 D; and quantifications are 
shown in Table S1), which is highly reminiscent of blebbistatin 
treatment. In addition, although short-term depletion (4 d) of 
NMMIIA caused little effects (control, 6 ± 4%; vs. NMMIIA 
depletion, 7 ± 3%), long-term depletion (>7 d) led to marked 
apoptosis in hESCs (NMMIIA-depleted cells, 32 ± 5%; non-
targeting shRNA control cells on day 8, 7 ± 3%; P < 0.001).   
The elevated apoptosis in NMMIIA-depleted cells was preceded 
by a robust reduction in the c-Myc protein (see Fig. 3 F; un-
published data). c-Myc is a transcription factor and acts as a key 
regulator of cell growth and survival. In contrast, depletion of 
NMMIIB had little effect on the pluripotency factors, colony 
formation, and long-term cell survival (Fig. 1, A and E; Table 
S1; and not depicted). The shRNA sequences targeting NMMIIA 
or NMMIIB effectively depleted their respective targets in H9 
cells,  demonstrating  high  specificity  of  shRNAs  (Fig.  1  F). 
These results suggest that NMMIIA but not NMMIIB is neces-
sary for colony formation, stability of the OCT-4–NANOG–SOX2 
circuitry, and long-term survival of hESCs. The requirement of 
NMMIIA for supporting the ESC state might explain in part the 
early developmental defects observed in NMMIIA-null mice.
NMMIIA modulates E-cadherin adhesion 
and protein expression in hESCs
We next assessed NMMIIA’s subcellular localization in hESCs. 
Immunofluorescence of NMMIIA was mainly distributed at 
cell–cell junctions, colocalizing with the adhesion molecule   
E-cadherin (Fig. 2 A). This raises the possibility that NMMIIA 
might regulate intercellular junctions in hESCs. Consistent with 
this idea, NMMIIA depletion for 4 d markedly impaired the ac-
cumulation of E-cadherin at the junctional sites and caused it to 
distribute diffusely or in punctuate structures in the cytoplasm 
(Fig. 2 B). Interestingly, although NMMIIB was also localized 
to cell–cell junctions (Fig. S2 C), its depletion failed to alter   
E-cadherin localization (not depicted). Similar to NMMIIA de-
pletion, blebbistatin treatment caused redistribution of E-cadherin 
immunofluorescence to the cytoplasm (Fig. 2 B). The effect of 
blebbistatin was rapid, altering E-cadherin localization within 
24 h of treatment (Fig. 2 B).
To further dissect how NMMIIA regulates E-cadherin, 
we asked whether NMMIIA was necessary for E-cadherin– 
dependent intercellular adhesion in hESCs. We used an estab-
lished adhesion assay (Verma et al., 2004) to assess the ability 
of cells to attach to the immobilized E-cadherin/Fc proteins 
(hE/Fc). In this assay, short-term blebbistatin treatment (2 h) 
robustly reduced the number of cells adhered to the E-cadherin 
substrate (Fig. 2 C), suggesting that NMMII activity is re-
quired for E-cadherin–mediated intercellular contact forma-
tion and adhesion.
NMMII-dependent cytoskeletal contractility has been im-
plicated as a key regulator of mechanical signals in a variety of 
cell types including stem cells (McBeath et al., 2004; Engler et al., 
2006; Chowdhury et al., 2010). In this study, we also showed 
that NMMII was necessary for E-cadherin–mediated mechani-
cal tension in hESCs. We applied traction force microscopy, 
which assesses the mechanical interactions between cells and 
the substrate, to determine the traction stress in cells adhered to 
hE/Fc-coated substrates with an elastic modulus of 8.5 kPa. 
This stiffness is in the range of normal tissues (1–10 kPa), as 
documented previously (Janmey and McCulloch, 2007). Single 
H9 cells were found to exert a mean traction stress of 650 Pa on 
the substrates (Fig. 2, D and E), whereas blebbistatin treatment 
(G) Quantification of the results shown in F. The y axis represents relative intensities (measured with ImageJ; National Institutes of Health) with values normalized 
to the signal (100%) at 0 h. Results from four separate experiments are shown. (H) Western blot analysis of E-cadherin protein in H9 cells with or without 
NMMIIA depletion. Asterisks indicate that the value for cells treated with blebbistatin differs statistically from the control (*, P < 0.05; **, P < 0.01; ***, 
P < 0.0001). Error bars indicate mean ± SEM.
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only slightly decreased (Fig. S2 D). Therefore, inhibiting   
E-cadherin activity or reducing E-cadherin expression in hESCs 
impaired cellular association, colony formation, and stability   
of the transcription factors. Furthermore, E-cadherin depletion 
mildly up-regulated markers for the three germ layers and   
trophoectoderm (Fig. S2 D and not depicted). The defects were 
highly reminiscent of those caused by NMMII inhibition or 
NMMIIA depletion.
Finally,  overexpression  of  E-cadherin  in  hESCs  nearly 
completely rescued the defects induced by NMMIIA depletion. 
Ectopic expression of E-cadherin caused H9 cells to maintain a 
high level of E-cadherin protein even with NMMIIA depleted. 
Sustained  E-cadherin  expression  in  NMMIIA-depleted  cells 
prevented colony disruption and the down-regulation of OCT-4, 
NANOG, SOX2, and c-Myc (Fig. 3 F, Fig. S2 E, and not de-
picted). Thus, E-cadherin was capable of supporting colony for-
mation and stability of the circuitry for pluripotency, although 
NMMIA expression was largely absent. Together, our results 
confirm and extend previous evidence (Conti et al., 2004;   
Shewan et al., 2005; Smutny et al., 2010), suggesting that   
E-cadherin serves as a bona fide target of NMMIIA in hESCs to 
control intercellular adhesion and the pluripotency circuitry.
NMMIIA controls E-cadherin expression  
via p120-catenin
p120-catenin is the prototypic member of a subfamily of Arma-
dillo domain proteins. It binds to the juxtamembrane region of 
cadherin intracellular domains (Thoreson et al., 2000). p120-
catenin ablation in mice and other vertebrates led to embryonic 
lethality (for review see McCrea and Park, 2007), demonstrat-
ing a critical role in early development. Earlier studies showed 
that p120-catenin regulates E-cadherin expression levels at the 
cell surface and modulates its signaling behavior (Davis et al., 
2003; Xiao et al., 2003; Wildenberg et al., 2006). Thus, we 
tested the possibility that p120-catenin might be involved in the 
regulation of E-cadherin expression by NMMIIA.
Human cells express multiple isoforms of p120-catenin 
(Keirsebilck et al., 1998). Isoforms 1–4 differ from each other 
by the start codon used, whereas additional combinations are 
based on the alternative use of exons A–C. Western blot analysis 
of protein lysates from hESCs with two monoclonal antibodies, 
one against isoforms 1 and 2 (6H11; Wu et al., 1998) and the 
other against all isoforms (15D2; Wu et al., 1998), recognized one 
and two major bands, respectively (Fig. 4 A, top). A side-by-side 
analysis of lysates from IMR-90, a human fibroblast cell line, 
indicated that the band of higher molecular mass might be iso-
form 1 (Fig. 4 A, bottom). Mesenchymal cells such as fibro-
blasts express p120-catenin isoform 1 (Mo and Reynolds, 1996; 
Keirsebilck et al., 1998). RT-PCR analysis of alternative splicing 
events at the 5 region confirmed that hESCs expressed mRNA 
of isoforms 1, 3, and (at a much lower level) 4 (Fig. S3 A). Based 
on  the  results  from  Western  blot  and  RT-PCR  analyses,   
we inferred that hESCs mainly express isoforms 1 and 3.   
In addition, RT-PCR analysis of alternative splicing at the 3 re-
gion suggested that hESCs expressed transcripts of isoforms A 
and C in high abundance and, to a much lesser degree, iso-
form B (Fig. S3 B).
markedly reduced the level of tractions (by 57%; to 280 Pa; 
Fig. 2, D and E).
Prolonged inhibition of NMMII in hESCs reduced the levels 
of E-cadherin protein. Blebbistatin treatment for 72 h caused   
both H9 and H1 cells to markedly down-regulate E-cadherin 
expression, which continued to decrease with longer treat-
ments (Fig. 2, F and G; and Fig. S1 D). The reduced E-cadherin 
expression was also observed in MMW2 hiPSCs (Fig. S1 E), 
indicating  conserved  modulation  in  human  pluripotent  stem 
cells. Interestingly, down-regulation of E-cadherin was either 
concomitant with or preceded the down-regulation of the pluripo-
tency proteins (Fig. 2, F and G; and Fig. S1 D). In keeping   
with the effect of blebbistatin, depletion of NMMIIA but not 
NMMIIB reduced E-cadherin levels (Fig. 2 H and not depicted). 
Thus, NMMIIA is required for E-cadherin–dependent intercel-
lular adhesion and mechanical tension and modulates the levels 
of E-cadherin protein in hESCs.
E-cadherin serves as a bona fide target of 
NMMIIA in hESCs
The effect of blebbistatin and NMMIIA depletion on E-cadherin– 
mediated  adhesion  and  E-cadherin  expression  led  us  to  ask 
whether decreased E-cadherin activity and levels might be re-
sponsible for the impaired cellular compaction and stability of 
the OCT-4–NANOG–SOX2 circuitry.
First, we assessed the effect of DECMA-1, a function-
blocking antibody that is thought to prevent homophilic binding 
between the E-cadherin extracellular domains (Hordijk et al., 
1997). Addition of 12 µg/ml DECMA-1 (sufficient to prevent 
E-cadherin functions in other cells types; Hordijk et al., 1997) 
to H9 cell clusters failed to affect cell morphology or alter ex-
pression of pluripotency markers (unpublished data). We rea-
soned that the lack of inhibition might be attributed to reduced 
accessibility of antibodies to cells that already establish junc-
tions, as demonstrated previously (Peignon et al., 2006). To test 
this, we seeded H9 cells as single cells and cultivated them in 
the presence of the DECMA-1 antibody, which, after a 4-d in-
cubation with the cells, markedly reduced the number (to 36%, 
relative to the nonspecific IgG-treated cells) and size of cell col-
onies (Fig. 3, A and B; and not depicted). Furthermore, in contrast 
to the control cells, which grew as compact colonies with well- 
defined smooth edges, colonies in the presence of DECMA-1 
exhibited small projections around the periphery (Fig. 3 A). 
Concomitant to the morphological changes, the levels of OCT-4, 
NANOG, SOX2, and c-Myc proteins were markedly reduced 
(Fig. 3 C and not depicted). Moreover, long-term treatment of 
cells with DECMA-1 (≥6 d) caused significant cell death (33 ± 8% 
vs. control cells on day 6, 5 ± 3%; P < 0.001), most likely be-
cause of the lack of proper intercellular adhesion.
Depletion of E-cadherin in hESCs led to similar results. 
Two specific shRNAs effectively depleted E-cadherin in H9 
cells, produced colonies with poor cellular association, reduced 
the levels of OCT-4, NANOG, SOX2, and c-Myc proteins (Fig. 3, 
D and E; and Table S1), and induced apoptosis after prolonged 
depletion (E-cadherin–depleted cells, 30 ± 8%; and nontarget-
ing shRNA control cells on day 8, 7 ± 3%; P < 0.001). The 
mRNA levels of POU5F1, SOX2, NANOG, and c-Myc were 637 Biomechanical signals control hESC functions • Li et al.
junctions to the cytoplasm (Fig. 4 D). In keeping with these   
results, NMMIIA depletion also led to substantial reduction of 
total p120-catenin protein (unpublished data).
In addition, p120-catenin was required for colony forma-
tion and the pluripotency maintenance circuitry of hESCs. Deple-
tion of p120-catenin by shRNAs sharply reduced the number of 
hESC colonies (to 35%), induced a significant down-regulation of 
OCT-4, NANOG, and SOX2 (Fig. 4, E and F; and Table S1), and 
caused marked apoptosis after longer treatment (not depicted). 
Treatment of H9 cells with blebbistatin caused marked re-
duction of all detectable p120-catenin protein isoforms (Fig. 4, 
B and C). The reduction occurred 24 h after the treatment and 
preceded that of E-cadherin protein (Fig. 2, F and G). Interest-
ingly, in contrast to the reduced protein levels, the amount   
of p120-catenin transcripts only decreased moderately after 
NMMII inhibition (Fig. S3 C), indicating that the regulation oc-
curred posttranscriptionally. In addition, short-term blebbistatin 
treatment (24 h) caused p120-catenin redistribution from cell–cell 
Figure 3.  E-cadherin serves as a bona fide target of NMMIIA in hESCs. (A) Phase-contrast images of nonspecific IgG and DECMA-1–treated cells 12 
and 96 h after treatments. The arrow points to an abnormal projection of a DEMCA-1–treated cell aggregate. Bar, 200 µm. (B) Quantification of colonies 
formed by H9 cells with IgG or DECMA-1 antibody treatment (4 d). Error bars represent the mean ± SEM of different numbers of colonies that were analyzed 
in multiple experiments. The values were normalized to the number (100%) of colonies formed by control cells. Asterisks indicate that the value for cells 
treated with DECMA-1 differs statistically from the control (*, P < 0.05). Cell aggregates with diameters >200 µm are defined as colonies. (C) Western blot 
analysis of OCT-4, NANOG, and SOX2 proteins in H9 cells treated with IgG or 12 µg/ml DECMA-1 antibody (4 d). For experiments in A–C, H9 cells 
were plated as single cells under feeder-free conditions and treated with nonspecific IgG or 12 µg/ml DECMA-1 antibody at the time of plating. (D) Phase-
contrast images of H9 cells infected with lentivirus containing nontargeting shRNA (NT shRNA) or E-cadherin–targeting shRNAs. Bar, 100 µm. (E) Western 
blot analysis of E-cadherin, OCT-4, SOX2, NANOG, and c-Myc proteins in H9 cells with or without E-cadherin depletion. For experiments in D and E, 
cells were analyzed 4 d after infection. Qualification of the results is shown in Table S1. (F) Western blot analysis of E-cadherin, NMMIIA, OCT-4, SOX2, 
NANOG, and c-Myc proteins in H9 cells treated with or without E-cadherin overexpression (E-cad) and NMMIIA depletion (NMMIIA KD). Qualification 
of the results is shown in Fig. S2 E.JCB • VOLUME 191 • NUMBER 3 • 2010   638
Figure 4.  NMMIIA modulates E-cadherin expression via p120-catenin. (A) Western blot analysis of p120-catenin proteins in H9 cells. (top) Two blots show-
ing bands recognized by 6H11 (left) or 15D2 (right) in H9 cells. (bottom) Western blot analysis of H9 and IMR-90 cell lysates with 6H11. (B) Western blot 
analysis of p120-catenin protein in H9 cells with or without 10 µM blebbistatin treatment for various time points. (C) Quantification of the experiment de-
scribed in B. The y axis represents relative intensities (measured with ImageJ) with values normalized to the signal (100%) at 0 h. Results from four separate 
experiments are shown as mean ± SEM. (D) Immunofluorescence experiments of p120-catenin in H9 cells with or without blebbistatin treatment. Fluorescent 
images of p120-catenin staining and phase-contrast image of cells are shown. Insets show fractions of fluorescence images at a higher magnification. Cells 
were treated with 10 µM blebbistatin for 24 h. The monoclonal antibody 15D2 was used. (E) Phase-contrast images of H9 cells treated with nontargeting 
shRNA (NT shRNA) or p120-catenin–targeting shRNAs. Cells were analyzed 4 d after lentiviral infection. (D and E) Bars, 100 µm. (F) Western blot analysis 
of p120-catenin (with 15D2), OCT-4, NANOG, and SOX2 proteins in H9 cells with or without p120-catenin depletion for 4 d. Qualification of the results is 639 Biomechanical signals control hESC functions • Li et al.
Yu et al., 2007; Park et al., 2008). We found that E-cadherin   
depletion markedly reduced the efficiency of reprogramming of 
human primary fibroblasts and keratinocytes (Fig. S4).
The effects of depleting - or -catenin  
in hESCs
In addition to p120-catenin, the cytoplasmic domain of E-cadherin 
can bind directly to -catenin, and the resulting E-cadherin– 
-catenin complex binds to -catenin. -Catenin dynamically 
remodels and polymerizes the associated actin cytoskeleton at 
the site of cadherin-mediated cell–cell adhesion (Ozawa and 
Kemler, 1992; Drees et al., 2005; Yamada et al., 2005). Coupling 
between E-cadherin and the actin cytoskeleton is thought to be 
necessary for the adhesion activity of E-cadherin (Nagafuchi and 
Takeichi, 1988).
We asked whether - and -catenin play a role in the regula-
tion of cellular association and pluripotency in hESCs. Immuno-
fluorescence of - and -catenin was predominantly located at 
intercellular junctions of hESC colonies (Fig. 5, A and B), imply-
ing a role in the regulation of intercellular adhesion. Depletion of 
- or -catenin for 4 d mildly reduced colony formation of hESCs 
(to 66% and 64%, respectively) and moderately reduced the level 
of OCT-4, NANOG, and SOX2 proteins (Fig. 5, C–F). The effects 
of - and -catenin depletion were similar (Fig. 5 and Table S1). 
Notably, although >60% of the catenin-depleted colonies exhib-
ited largely normal compact morphology, their periphery appeared 
to be more spread out than the control colonies (Fig. 6, C and E). 
These moderate defects of - and -catenin depletion indicate that 
these catenins were partially involved in the regulation of inter-
cellular adhesion and the pluripotency circuitry in hESCs.
It was previously shown that E-cadherin homophilic bind-
ing triggers the Rac signaling pathway (Kovacs et al., 2002). 
Thus, we tested the possibility that Rac might mediate E-cadherin’s 
effects on pluripotency in hESCs. Two specific shRNAs effec-
tively depleted Rac1 in hESCs (Fig. S5 A). However, they failed 
to affect hESC colony formation or the expression of pluripo-
tency markers (Fig. S5 B). These results suggest that Rac1 is 
not responsible for the effects of E-cadherin in hESCs.
Discussion
In conclusion, we identified critical components and signaling 
mechanisms  that  control  intercellular  adhesion  and  cellular 
structure, maintain stability of the transcriptional pluripotency 
circuitry and c-Myc expression, and support long-term survival 
in  hESCs. A  highly  integrated  signaling  network  containing 
NMMIIA, E-cadherin, and p120-catenin is uncovered (Fig. 6). 
In  this  network,  NMMIIA  regulates  E-cadherin–mediated 
adhesion activity and the cellular levels of E-cadherin. The latter 
p120-catenin depletion slightly decreased POU5F1, SOX2, and 
NANOG mRNA levels and moderately up-regulated markers for 
the three germ layers and trophoectoderm (Fig. S3 D). These re-
sponses were highly reminiscent of those caused by E-cadherin 
depletion. The shRNAs used in these experiments targeted all 
p120 isoforms. Consistent with earlier findings (Davis et al., 
2003; Xiao et al., 2003), p120-catenin depletion markedly re-
duced the level of E-cadherin protein in hESCs (Fig. 4 G).
Together, these data suggest that p120-catenin acts as a 
downstream effector of NMMIIA to regulate E-cadherin expres-
sion levels in hESCs. This inference was confirmed by the effect 
of ectopic expression of p120-catenin, which nearly completely 
rescued the decrease in E-cadherin protein levels in hESCs caused 
by blebbistatin treatment. In addition, p120-catenin overexpres-
sion largely rescued the defects in colony formation and the re-
duction in OCT-4, SOX2, and NANOG protein levels (Fig. 4 H, 
Fig. S3 E, and not depicted). Isoform 1A of p120-catenin, which 
was highly expressed in hESCs, was used for overexpression 
(Fig. 4 A; and Fig. S3, A and B).
p120-catenin and E-cadherin are coupled 
reciprocally to stabilize E-cadherin adhesion
The modulation of p120-catenin and E-cadherin appeared to   
be bidirectional in hESCs. Fig. 4 I shows that inhibition of   
E-cadherin with the DECMA-1 antibody drastically reduced the 
level of p120-catenin protein, which was associated with reduced 
E-cadherin protein levels. Similarly, depletion of E-cadherin   
in hESCs by shRNAs also led to reduction of p120-catenin   
protein levels (Fig. 4 J). Interestingly, the reciprocal modulation 
appears lacking in epithelial cells: the absence of E-cadherin 
fails  to  reduce  the  levels  of  p120-catenin,  which  becomes 
stranded in the cytoplasm (Thoreson et al., 2000).
It appears that the major role of p120-catenin is to support 
E-cadherin expression and E-cadherin–mediated intercellular 
adhesion, as suggested by experiments with ectopic expression 
of E-cadherin in hESCs with p120-catenin depletion (Fig. 4 K). 
We overexpressed E-cadherin in H9 cells followed by treatment 
with p120-catenin–targeting shRNAs. Although p120-catenin 
protein was nearly completely depleted, ectopic expression of 
E-cadherin was capable of supporting colony formation and 
preventing the down-regulation of OCT-4, SOX2, NANOG, and 
c-Myc proteins in p120-catenin–depleted cells (Fig. 4 K, Fig. S3 F, 
and not depicted).
Depletion of E-cadherin impairs directed 
somatic reprogramming
Murine and human somatic cells can be reprogrammed directly 
to pluripotency by ectopic expression of a subset of transcription 
factors (Takahashi and Yamanaka, 2006; Takahashi et al., 2007;   
shown in Table S1. (G) Western blot analysis of p120-catenin (15D2) and E-cadherin proteins in H9 cells 4 d after p120-catenin depletion. (H) Western blot 
analysis of p120-catenin (15D2), E-cadherin, OCT-4, and SOX2 proteins in H9 cells with or without isoform 1A of p120-catenin overexpression (p120) and 
10 µM blebbistatin treatment for 4 d. Qualification of the results is shown in Fig. S3 E. Similar results were observed with NANOG protein (not depicted). 
(I) Western blot analysis of p120-catenin (15D2) and E-cadherin proteins in H9 cells 4 d after the treatment of nonspecific IgG or 12 µg/ml DECMA-1.   
(J) Western blot analysis of p120-catenin (15D2) and E-cadherin proteins in H9 cells 4 d after E-cadherin depletion. (K) Western blot analysis of E-cadherin, 
p120-catenin, OCT-4, SOX2, NANOG, and c-Myc proteins in H9 cells with or without E-cadherin overexpression and p120-catenin depletion (p120 KD) 
for 4 d. Qualification of the results is shown in Fig. S3 F.
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plays an active role in generating or transmitting signals that 
control the functions of hESCs. We present evidence that 
NMMIIA is necessary not only for E-cadherin-mediated inter-
cellular adhesion and mechanical tension, but also for stability of 
p120-catenin. Inhibition of NMMII causes the level of p120-
catenin protein to decrease within 24 h, which in turn reduces   
E-cadherin expression levels in hESCs. Our results add to emerg-
ing evidence that cellular mechanics and myosin II-dependent 
cytoskeletal contractility are key regulators of fate determination 
in stem cells. In an earlier study, human mesenchymal stem cells 
(hMSCs) are shown to specify lineage and commit to pheno-
types with extreme sensitivity to tissue level elasticity (Engler   
et al., 2006). Inhibition of NMMII blocks all elasticity directed   
lineage specification, implicating mechanical factors in the   
regulation of the directed differentiation. In a separate study, 
McBeath et al. (2004) showed that cell shape regulates commit-
ment of hMSCs to adipocyte or osteoblast fate, which requires 
actin-myosin-generated tension. The critical role of mechani-
cal and physical factors has also been revealed in pluripotent 
response is mediated by p120-catenin, which requires NMMIIA 
to stabilize and in turn controls E-cadherin levels. Furthermore, 
we have revealed a bidirectional cross-modulation between   
E-cadherin and p120-catenin that promotes localized accumula-
tion of E-cadherin at intercellular junctions. The effects of   
E-cadherin on hESC structures and functions might be mediated 
partially by - and -catenin or other E-cadherin–dependent 
mechanical and biochemical signals (Fig. 6, dashed lines). Our 
results unveil a mechanobiochemical mechanism central to   
multifaceted  functions  of  hESCs  and  provide  mechanistic   
insights into microenvironmental regulation of hESC identity.
Integration of mechanical and  
biochemical signals
The model in Fig. 6 suggests closely integrated mechanical and 
biochemical signals that cooperate to regulate intercellular adhe-
sion  and  colony  structures  during  undifferentiated  growth  of 
hESCs. In this scenario, NMMIIA-based contractility does not 
serve simply as a read-out of intracellular signals but, instead, 
Figure 5.  The effects of depleting - and -catenin on colony formation and pluripotency. (A and B) Immunofluorescence experiments of -catenin (A) 
and -catenin (B) in H9 cells. The corresponding phase-contrast images are also shown. The insets show fractions of fluorescence images at a higher mag-
nification. (C) Phase-contrast images of H9 cells treated with nontargeting shRNA (NT shRNA) or shRNAs targeting -catenin. (D) Western blot analysis of 
-catenin, OCT-4, NANOG, and SOX2 proteins in H9 cells with or without 4-d depletion of -catenin. (E) Phase-contrast images of H9 cells treated with 
nontargeting shRNA or shRNAs targeting -catenin. (F) Western blot analysis of -catenin, OCT-4, NANOG, and SOX2 proteins in H9 cells with or without 
4-d depletion of -catenin. (D and F) Quantification of the results is shown in Table S1. Bars, 100 µm.641 Biomechanical signals control hESC functions • Li et al.
mechanical regulation with the biochemical signals may pro-
vide greater robustness to the feedback loop and create addi-
tional levels of regulation for E-cadherin–mediated intercellular 
adhesion, which might be essential for the diverse fate decisions 
hESCs (or other pluripotent stem cells) are poised to make in 
response to various extrinsic an intrinsic cues. More complete 
understanding of the detailed mechanisms underlying the feed-
back regulation and mechanical–biochemical integration awaits 
future experimentation.
How might E-cadherin regulate the 
transcriptional circuitry for pluripotency?
Our data confirm and extend previous evidence, suggesting that 
the OCT-4–SOX2–NANOG circuitry is intimately linked to   
intercellular adhesion and colony integrity of hESCs during   
undifferentiated growth. Disruption of cellular association and 
compact structures of hESCs in each case causes concomitant 
down-regulation of the transcription factors. Our results have also 
assigned an essential role for E-cadherin in the maintenance of 
the hESC circuitry: depletion or inhibition of E-cadherin induces 
down-regulation of OCT-4, SOX2, and NANOG within 4 d.   
Although inhibition (or depletion) of NMMIIA and p120-
catenin leads to similar defects, our findings suggest that the ef-
fects of NMMIIA and p120-catenin are mediated by E-cadherin. 
Ectopic expression of E-cadherin in hESCs supports stability of 
the pluripotency circuitry, although NMMIIA and p120 catenin 
are largely absent.
How might E-cadherin–mediated cell–cell adhesion regu-
late the transcriptional circuitry for pluripotency? Our results 
imply two possible mechanisms. First, - or -catenin deple-
tion produces defects that partially recapitulate those caused by 
E-cadherin depletion/inhibition. Recent studies demonstrated 
that cadherin clusters at the plasma membranes cause the re-
lease of -catenin dimers, which in turn induces actin bundling 
by  reportedly  competing  with Arp2/3-binding  sites  on  actin 
(Drees et al., 2005; Yamada et al., 2005). Thus, these results in-
dicate that dynamic actin assembly mediated by the interactions 
between E-cadherin and - and -catenin might be partially   
involved in the signal transduction from intercellular adhesion 
sites to the nuclear pluripotency circuitry (Fig. 6). Second, we 
show that E-cadherin–mediated adhesion induces mechanical 
tension, which could transduce information to influence the   
pluripotency network (Fig. 6, dashed lines). Other speculative 
mechanisms alone or in combination could also contribute to 
the cross-modulation between cellular compaction and pluripo-
tency.  Unidentified  molecular  components  downstream  of   
E-cadherin adhesion in hESCs could transmit signals to stabi-
lize the core transcriptional circuitry. In addition, it might be 
that E-cadherin–dependent intercellular adhesion is a prerequi-
site for the activation of pluripotency-promoting signaling path-
ways such as those mediated by bFGF, TGF-, and mTOR.
Materials and methods
Cell culture
hESC lines H9 and H1 (WiCell Research Institute, Madison, WI) were rou-
tinely maintained under feeder conditions as previously described (Thomson   
et al., 1998). In brief, primary mouse embryonic fibroblasts (MEFs) prepared 
stem cells. Application of local stress induces cell spreading and 
down-regulation of OCT-4 in mESCs, and the spreading and 
down-regulation  depend  upon  NMMII  activity  (Chowdhury   
et al., 2010). Our results provide an additional example of me-
chanical regulation of fate decisions in stem cells. In addition, 
our data begin to reveal some molecular details underlying the 
integration of mechanical and biochemical signals.
Our findings suggest a potential positive feedback loop that 
controls localized accumulation of E-cadherin at the intercellular 
adhesion sites of hESCs. The components of the feedback loop in-
clude E-cadherin and p120-catenin. First, inhibition (or depletion) 
of one protein markedly decreases the level of the other, demon-
strating bidirectional regulation between them. Furthermore,   
phenotypes of hESCs with E-cadherin or p120-catenin depletion 
are remarkably similar. One arc of the feedback loop, in which 
p120-catenin regulates the cellular levels of E-cadherin, is in keep-
ing with the previously reported role of p120-catenin in stabilizing 
cadherin junctions in cell types including epithelial and endothe-
lial cells (Davis et al., 2003; Xiao et al., 2003). Interestingly, the 
reciprocal arc, in which E-cadherin modulates the accumulation 
of p120-catenin, has not been documented. In epithelial cells, the 
absence of E-cadherin fails to reduce the levels of p120-catenin, 
which instead becomes stranded in the cytoplasm (Thoreson et al., 
2000). Thus, the potential feedback loop might be a feature 
uniquely related to the identity of ESCs. We envision that the   
positive feedback regulation could lead to rapid and robust accu-
mulation of E-cadherin protein at the intercellular junctions, thus 
allowing hESCs to quickly establish, consolidate, and strengthen 
their cellular association and colony structures during undifferenti-
ated growth. Interestingly, the stability of the putative feedback loop 
depends on the input from NMMIIA, which controls E-cadherin 
levels via p120-catenin. We also envision that integration of   
Figure 6.  Integrated biochemical and mechanical signals regulate multi-
faceted functions of hESCs. A model is shown. See Discussion for details.JCB • VOLUME 191 • NUMBER 3 • 2010   642
the number of ESC-like colonies divided by the total number of cells plated on 
MEFs after infection.
Western blotting
Cells were lysed directly with Laemmli 2× sample buffer (Bio-Rad Laborato-
ries). Lysates were separated by SDS-PAGE and analyzed by Western blotting. 
Dilutions used for various antibodies are described in Table S2. The blots were 
developed using SuperSignal West Pico Chemiluminescent Substrate (Thermo 
Fisher Scientific).
Immunofluorescence
hESCs  cultured  under  feeder-free  conditions  were  washed  twice  with 
cold PBS, fixed with 3.7% paraformaldehyde for 20 min at room tem-
perature, permeabilized with 0.1% Triton X-100 in PBS, and blocked 
with PBS containing 2% normal donkey serum. Samples were incubated 
overnight  at  4°C  with  primary  antibody  (Table  S2)  followed  by  two 
washes with PBS and a 1-h room temperature incubation with Alexa 
Fluor 488 (or 594)–conjugated secondary antibody. Nuclei were counter-
stained with DAPI (Sigma-Aldrich) for 5 min. Phase-contrast and fluor-
escent images were collected with a 10× 0.3 NA EC Plan Neofluar Ph1 
objective (Carl Zeiss, Inc.) on a microscope (Axiovert 200M; Carl Zeiss, 
Inc.). All images were collected with a cooled charge-coupled device 
camera (AxioCam MR3; Carl Zeiss, Inc.) at room temperature and pro-
cessed using Photoshop (Adobe).
AP staining
An  AP  detection  kit  (Millipore)  was  used  following  the  manufacturer’s   
instructions. In brief, cells were fixed with 4% paraformaldehyde for 2 min 
and washed and stained with the staining solution for 15 min at room tem-
perature. After three washes, cells were visualized using light microscopy.
RNA preparation and real-time PCR
For real-time PCR, total RNA was isolated from cells with Trizol reagent   
(Invitrogen) and purified with RNeasy mini kit (QIAGEN) following the manu-
facturer’s instructions. cDNA was synthesized from the purified RNA using   
a reverse transcription system (Promega) with random primers. Real-time 
PCR was performed using SYBR green PCR kit (QuantiTech; QIAGEN).   
Reactions were performed in 25 µl containing 2× 12.5 µl SYBR green mix, 
10× primer solution (2.5 µl mixture of forward and reverse primers), 2 µl 
cDNA, and nuclease-free water. The PCR program following QIAGEN pro-
tocols was used as described previously (Zhou et al., 2009): 95°C for   
15 min followed by 40 cycles of 94°C for 15 s, 56°C for 15 s, and 72°C 
for 34 s. All gene-specific primers were generated based on sequences at 
PrimerBank or purchased from QIAGEN (Table S4). -Actin was used to 
normalize gene expression levels.
RT-PCR analysis of p120-catenin isoforms
The pattern of p120-catenin expression in hESCs was analyzed as described 
previously (Keirsebilck et al., 1998). In brief, total RNA was prepared from 
hESCs, and cDNA was synthesized from the purified RNA using a reverse 
transcription system (Promega) with oligo(dT) primers. The synthesized cDNA 
was amplified by PCR in reactions containing cDNA template, p120-catenin 
isoform-specific primers (Table S4), 0.25 U Taq DNA polymerase, and de-
oxynucleoside 5-triphosphates. The following program was used: 94°C for 
5 min, 80°C for 1 min followed by 35 cycles of 94°C for 1 min, 55°C for 
45 s, 72°C for 1.5 min, and a final extension at 72°C for 10 min. The PCR 
products were analyzed on a 1.5% agarose gel.
E-cadherin adhesion assay
Adhesion of hESCs to hE/Fc-coated substrata was measured by the resis-
tance to detachment as previously described (Verma et al., 2004). In brief, 
nitrocellulose-coated 96-well plates were incubated with 0.1% hE/Fc (in 
HBSS containing 5 mM CaCl2) overnight at 4°C. The plate was blocked 
with 10 mg/ml bovine serum albumin for 2 h at 4°C. H9 cells were pre-
treated with Y-27632 for 2 h and digested with accutase (Invitrogen) for   
7 min. Freshly isolated cells were allowed to attach to substrata for 2 h at 
37°C in a CO2 incubator with or without 10 µM blebbistatin and subjected 
to detachment by shear stress created by systematic pipetting. Cells re-
maining adherent to the wells were incubated with calcain-AM for 30 min, 
washed, and measured with a fluorescence plate reader (EX, 485 nm; 
and EM, 535 nm; CytoFluor 2300; Millipore).
Apoptosis assay
To determine the rate of apoptosis in hESCs, H9 cells with or without vari-
ous treatments were dissociated into single cells using 0.25% trysin-EDTA 
from embryos of pregnant CF-1 mice (day 13.5 of gestation; Charles River) 
were cultured in Dulbecco’s minimum essential medium (DMEM) containing 
10% FBS (Hyclone) and 1 mM nonessential amino acid and penicillin/ 
streptomycin and mitotically inactivated by -irradiation. H1 and H9 cells 
were cultured on irradiated MEFs in media containing DMEM/F12, 20% 
knockout serum replacement, 4 ng/ml bFGF (Invitrogen), 1% nonessential 
amino acid, 1 mM glutamine, and 0.1 mM -mercaptoethanol. For feeder-
free cultures, cells were cultured on Matrigel (BD)-coated plates in MEF- 
conditioned medium as previously described (Xu et al., 2001). MMW2 
hiPSCs (Mali et al., 2010) were cultured under the same conditions as hESCs. 
W4/129 mESCs (Taconic) were cultured on 0.1% gelatin-coated 6-well plates 
in media containing DMEM (high glucose; Invitrogen), 15% FBS, 1,000 U/ml 
LIF (Millipore), 0.1 mM nonessential amino acids, 2 mM l-glutamine, 1 mM 
sodium pyruvate, 10
6 M 2-mercaptoethanol, and 100 U/ml penicillin/
streptomycin. Medium changes were administered every other day. HEK293T, 
HT29, and IMR90 cells were purchased from American Type Culture Collec-
tion (ATCC) and cultured following ATCC recommendations.
Inhibitor and antibodies
Blebbistatin was purchased from EMD. Rat monoclonal antibody against 
E-cadherin  (DECMA-1)  was  obtained  from  Abcam.  Antibodies  against 
p120-catenin (15D2 and 6H11) were described previously (Wu et al., 
1998).  The  polyclonal  antibody  against  -catenin  was  provided  by   
B. Gumbiner (University of Virginia, Charlottesville, VA; Funayama et al., 
1995).  Alexa  Fluor  488–  and  594–conjugated  secondary  antibodies 
were obtained from Invitrogen. All antibodies for Western and/or immuno-
fluorescence analyses are listed in Table S2.
DNA constructs
Full-length E-cadherin cDNA was amplified from pCDNA3 containing   
human E-cadherin–YFP (provided by A. Yap, The University of Queensland, 
Brisbane, Queensland, Australia) by PCR using forward primer hE-cad-wt-F 
(Table S4) and reverse primer hE-cad-wt-R (Table S4). The PCR product was 
cloned into PCR8/GW/TOPO entry vector (Invitrogen). The final over-
expression construct was attained by recombination of the resulting entry 
clone with the pENTR TOPO vector containing the EF1- promoter and the 
2k7neo lentiviral vector as previously described (Zhou et al., 2009). Posi-
tive clones containing the EF-1- promoter and human E-cadherin cDNA 
were confirmed by sequencing.
Full-length human p120 1A cDNA was amplified from pMS containing 
isoform 1A of human p120-catenin by PCR using forward primer hp120-1AF 
(Table S4) and reverse primer hp120-1AR (Table S4) modified to contain SpeI 
and EcoRI recognition sites, respectively. The PCR product was ligated into 
pSin-EF2-Nanog-Pur (Addgene) by replacing NANOG cDNA after SpeI and 
EcoRI restriction digestions. Positive clones were verified by sequencing.
Lentivirus production and hESC infection
For  shRNA-mediated  gene  knockdown,  pLKO  vectors  containing  different 
shRNA sequences (Sigma-Aldrich; Table S3) were used to package virus with 
Viralpower Lentivirus Packaging System (Invitrogen) as previously described 
(Zhou et al., 2009). For lentiviral infection, hESCs cultured on MEFs were dis-
sociated as clusters and plated onto Matrigel-coated plates. Lentivirus (MOI, 
10–200) was directly added into MEF-conditioned medium containing   
6 µg/ml polybrene (Sigma-Aldrich) and incubated for 20 h before medium 
change. Selection commenced 48 h after infection with 2 ug/ml puromycin. 
Cells were analyzed 4–5 d after selection.
For  ectopic  expression  of  human  E-cadherin  and  p120-catenin  in 
hESCs, lentiviral-mediated delivery and selection (400 µg/ml G418 or   
2 µg/ml puromycin, respectively) were performed after the aforementioned 
procedures. For combined overexpression and depletion experiments, cells 
were coinfected with shRNA and overexpression cassette lentivirus followed 
by selection and analysis.
Induction of directed reprogramming
The lentiviral constructs containing overexpression cassettes for OCT-4, SOX2, 
NANOG, Lin-28, KLF4, and c-Myc were obtained from Addgene. Lentivirus 
for the six factors was mixed at equal amounts in media containing 6 µg/ml 
polybrene and administered to IMR-90 (passages 1–5; ATCC) or human neo-
natal keratinocytes (passages 1–5; Invitrogen) together with lentivirus contain-
ing nontargeting shRNA or E-cadherin–targeting shRNA. 48 h after infection, 
cells (10
7 cells) were dissociated into single cells by trypsin and plated onto 
culture dishes coated with -irradiated MEFs. Cell colonies typically emerged 
within 4–6 (keratinocytes) or 8–9 d (IMR-90). The number of ESC-like colonies 
was counted 2 wk after the initial plating. ESC-like colonies were scored based 
on morphology and AP activity. Reprogramming efficiency was calculated as 643 Biomechanical signals control hESC functions • Li et al.
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propidium iodide were added to the suspension and incubated for 20 min 
at room temperature. Cells were subsequently analyzed using FACSDiva 
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Polyacrylamide gel substrates, traction force microscopy, and  
data analysis
Polyacrylamide gels were prepared as described previously (Pelham and 
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